Clinical Trial Update: Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

View source ↗

Summary

A VA-sponsored study (Study 1) completed and posted results on developing objective measures for Levodopa-induced dyskinesia in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia
• Parkinson Disease

Drugs mentioned

• levodopa (levodopa)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Dyskinesias, Movement Disorders | Status: COMPLETED | Results posted: 2014-11-26